Abstract:Smartphone-based tele-dermatology assumes that colorimetric calibration ensures clinical reliability, yet this remains untested for underrepresented skin phototypes. We investigated whether standard calibration translates to reliable clinical biomarkers using 43,425 images from 965 Korean subjects (Fitzpatrick III-IV) across DSLR, tablet, and smartphone devices. While Linear Color Correction Matrix (CCM) normalization reduced color error by 67-77% -- achieving near-clinical accuracy (Delta E < 2.3) -- this success did not translate to biomarker reliability. We identify a phenomenon termed "color-clinical decoupling": despite perceptual accuracy, the Individual Typology Angle (ITA) showed poor inter-device agreement (ICC = 0.40), while the Melanin Index achieved good agreement (ICC = 0.77). This decoupling is driven by the ITA formula's sensitivity to b* channel noise and is further compounded by anatomical variance. Facial region accounts for 25.2% of color variance -- 3.6x greater than device effects (7.0%) -- challenging the efficacy of single-patch calibration. Our results demonstrate that current colorimetric standards are insufficient for clinical-grade biomarker extraction, necessitating region-aware protocols for mobile dermatology.
Abstract:Despite the efficient market hypothesis, many studies suggest the existence of inefficiencies in the stock market, leading to the development of techniques to gain above-market returns, known as alpha. Systematic trading has undergone significant advances in recent decades, with deep learning emerging as a powerful tool for analyzing and predicting market behavior. In this paper, we propose a model inspired by professional traders that look at stock prices of the previous 600 days and predicts whether the stock price rises or falls by a certain percentage within the next D days. Our model, called DeepStock, uses Resnet's skip connections and logits to increase the probability of a model in a trading scheme. We test our model on both the Korean and US stock markets and achieve a profit of N\% on Korea market, which is M\% above the market return, and profit of A\% on US market, which is B\% above the market return.